Lung and thymic carcinoids: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

被引:170
作者
Baudin, E. [1 ]
Caplin, M. [2 ]
Garcia-Carbonero, R. [3 ]
Fazio, N. [4 ]
Ferolla, P. [5 ,6 ]
Filosso, P. L. [7 ]
Frilling, A. [8 ]
de Herder, W. W. [9 ]
Hoersch, D. [10 ]
Knigge, U. [11 ,12 ]
Korse, C. M. [13 ]
Lim, E. [14 ,15 ]
Lombard-Bohas, C. [16 ]
Pavel, M. [17 ]
Scoazec, J. Y. [18 ]
Sundin, A. [19 ]
Berruti, A. [20 ]
机构
[1] Gustave Roussy, Endocrine Oncol & Nucl Med Unit, Villejuif, France
[2] Royal Free Hosp, Ctr Gastroenterol, Neuroendocrine Tumour Unit, London, England
[3] Hosp Univ 12 Octubre, Inst Invest Sanitaria Hosp Octubre Imas12 12, Oncol Dept, UCM,CNIO,CIBERONC, Madrid, Spain
[4] IRCCS, European Inst Oncol IEO, Div Gastrointestinal Med Oncol & Neuroendocrine T, Milan, Italy
[5] Umbria Reg Canc Network, Dept Med Oncol, Multidisciplinary NET Grp, Perugia, Italy
[6] Univ Perugia, Perugia, Italy
[7] Univ Torino, Unit Thorac Surg Corso Dogliotti, Dept Surg Sci, Turin, Italy
[8] Imperial Coll London, Dept Surg & Canc, London, England
[9] Erasmus MC, ENETS Ctr Excellence, Sect Endocrinol, Dept Internal Med, Rotterdam, Netherlands
[10] ENETS Ctr Excellence Zentralklin Bad Berka, Bad Berka, Germany
[11] Copenhagen Univ Hosp, Rigshosp, ENETS Ctr Excellence, Dept Surg, Copenhagen, Denmark
[12] Copenhagen Univ Hosp, Rigshosp, ENETS Ctr Excellence, Dept Endocrinol, Copenhagen, Denmark
[13] Netherlands Canc Inst, Dept Lab Med, Amsterdam, Netherlands
[14] Imperial Coll, London, England
[15] Royal Brompton Hosp, Acad Div Thorac Surg, London, England
[16] Hosp Civils Lyon, Hop E Herriot, Canc Inst, Lyon, France
[17] Friedrich Alexander Univ Erlangen Nurnberg, Endocrinol, Dept Med 1, Erlangen, Germany
[18] Gustave Roussy, Dept Pathol, Villejuif, France
[19] Uppsala Univ, Dept Radiol & Nucl Med, Dept Surg Sci IKV, Uppsala, Sweden
[20] Univ Brescia, Med Oncol Unit, Dept Med & Surg Specialties, Radiol Sci & Publ Hlth, Brescia, Italy
关键词
lung carcinoids; thymic carcinoids; diagnosis; characterisation; prognosis; therapy; PULMONARY NEUROENDOCRINE TUMORS; RECEPTOR RADIONUCLIDE THERAPY; ENETS CONSENSUS GUIDELINES; ENDOCRINE NEOPLASIA TYPE-1; CHROMATIN-REMODELING GENES; PROGNOSTIC-FACTORS; PLUS OCTREOTIDE; ADJUVANT CHEMOTHERAPY; EUROPEAN ASSOCIATION; SOMATOSTATIN ANALOG;
D O I
10.1016/j.annonc.2021.01.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:439 / 451
页数:13
相关论文
共 105 条
[1]   Somatostatin Analogs Improve Respiratory Symptoms in Patients With Diffuse Idiopathic Neuroendocrine Cell Hyperplasia [J].
Al-Toubah, Taymeyah ;
Strosberg, Jonathan ;
Halfdanarson, Thorvardur R. ;
Oleinikov, Kira ;
Gross, David J. ;
Haider, Mintallah ;
Sonbol, Mohamad Bassam ;
Almquist, Daniel ;
Grozinsky-Glasberg, Simona .
CHEST, 2020, 158 (01) :401-405
[2]   Capecitabine and Temozolomide in Advanced Lung Neuroendocrine Neoplasms [J].
Al-Toubah, Taymeyah ;
Morse, Brian ;
Strosberg, Jonathan .
ONCOLOGIST, 2020, 25 (01) :E48-E52
[3]   Adjuvant Chemotherapy Does Not Confer Superior Survival in Patients With Atypical Carcinoid Tumors [J].
Anderson, Kevin L., Jr. ;
Mulvihill, Michael S. ;
Speicher, Paul J. ;
Yerokun, Babatunde A. ;
Gulack, Brian C. ;
Nussbaum, Daniel P. ;
Harpole, David H., Jr. ;
D'Amico, Thomas A. ;
Berry, Mark F. ;
Hartwig, Matthew G. .
ANNALS OF THORACIC SURGERY, 2017, 104 (04) :1221-1230
[4]   Bronchopulmonary Neuroendocrine Neoplasms and Their Precursor Lesions in Multiple Endocrine Neoplasia Type 1 [J].
Bartsch, Detlef K. ;
Albers, Max B. ;
Lopez, Caroline L. ;
Apitzsch, Jonas C. ;
Walthers, Eduard M. ;
Fink, Ludger ;
Fendrich, Volker ;
Slater, Emily P. ;
Waldmann, Jens ;
Anlauf, Martin .
NEUROENDOCRINOLOGY, 2016, 103 (3-4) :240-247
[5]   Bevacizumab plus octreotide and metronomic capecitabine in patients with metastatic well-to-moderately differentiated neuroendocrine tumors: the xelbevoct study [J].
Berruti, Alfredo ;
Fazio, Nicola ;
Ferrero, Anna ;
Brizzi, Maria Pia ;
Volante, Marco ;
Nobili, Elisabetta ;
Tozzi, Lucia ;
Bodei, Lisa ;
Torta, Mirella ;
D'Avolio, Antonio ;
Priola, Adriano Massimiliano ;
Birocco, Nadia ;
Amoroso, Vito ;
Biasco, Guido ;
Papotti, Mauro ;
Dogliotti, Luigi .
BMC CANCER, 2014, 14
[6]   Outcome Analysis of First-line Somatostatin Analog Treatment in Metastatic Pulmonary Neuroendocrine Tumors and Prognostic Significance of 18FDG-PET/CT [J].
Bongiovanni, Alberto ;
Recine, Federica ;
Riva, Nada ;
Foca, Flavia ;
Liverani, Chiara ;
Mercatali, Laura ;
Nicolini, Silvia ;
Pieri, Federica ;
Amadori, Dino ;
Ibrahim, Toni .
CLINICAL LUNG CANCER, 2017, 18 (04) :415-420
[7]   Guideline for PET/CT imaging of neuroendocrine neoplasms with 68Ga-DOTA-conjugated somatostatin receptor targeting peptides and 18F-DOPA [J].
Bozkurt, Murat Fani ;
Virgolini, Irene ;
Balogova, Sona ;
Beheshti, Mohsen ;
Rubello, Domenico ;
Decristoforo, Clemens ;
Ambrosini, Valentina ;
Kjaer, Andreas ;
Delgado-Bolton, Roberto ;
Kunikowska, Jolanta ;
Oyen, Wim J. G. ;
Chiti, Arturo ;
Giammarile, Francesco ;
Fanti, Stefano .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (09) :1588-1601
[8]   Long-Term Efficacy, Survival, and Safety of [177Lu-DOTA0, Tyr3] octreotate in Patients with Gastroenteropancreatic and Bronchial Neuroendocrine Tumors [J].
Brabander, Tessa ;
van der Zwan, Wouter A. ;
Teunissen, Jaap J. M. ;
Kam, Boen L. R. ;
Feelders, Richard A. ;
de Herder, Wouter W. ;
van Eijck, Casper H. J. ;
Franssen, Gaston J. H. ;
Krenning, Eric P. ;
Kwekkeboom, Dik J. .
CLINICAL CANCER RESEARCH, 2017, 23 (16) :4617-4624
[9]   Surgical treatment of synchronous multiple neuroendocrine lung tumours (case series): is more always better? [J].
Brandolini, Jury ;
Bertolaccini, Luca ;
Pardolesi, Alessandro ;
Solli, Piergiorgio .
ANNALS OF TRANSLATIONAL MEDICINE, 2017, 5 (21)
[10]   Global Consultation on Cancer Staging: promoting consistent understanding and use [J].
Brierley, James ;
O'Sullivan, Brian ;
Asamura, Hisao ;
Byrd, David ;
Huang, Shao Hui ;
Lee, Anne ;
Pineros, Marion ;
Mason, Malcolm ;
Moraes, Fabio Y. ;
Roesler, Wiebke ;
Rous, Brian ;
Torode, Julie ;
van Krieken, J. Han ;
Gospodarowicz, Mary .
NATURE REVIEWS CLINICAL ONCOLOGY, 2019, 16 (12) :763-771